| Autor: |
Kiersnowska-Rogowska B; Klinika Hematologil Akademii Medycznej w Białymstoku., Izycka A, Jabłońska E, Rogowski F, Parfieńczyk A |
| Jazyk: |
polština |
| Zdroj: |
Przeglad lekarski [Przegl Lek] 2005; Vol. 62 (8), pp. 772-4. |
| Abstrakt: |
The aim of this study was to estimate sPECAM-1, sICAM-2 and TNF-alpha and IL-18 concentrations in serum patients with chronic myelogenic leukemia. The results indicate of increased level sPECAM-1, sICAM-2 and TNF-alpha, IL-18 concentrations in serum patients with chronic myelogenic leukemia. Elevation levels of sPECAM-1 and sICAM-2 may lead to inhibit of making myelogenic leukemia cells infiltrations through the block of surface their receptors in patients with CML. High concentration of TNF-alpha and 11-18 in blood serum may indicate high expression of sPECAM-1 by activated specific enzymes responsible for releasing sPECAM-1. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
